Kingsview Wealth Management LLC Sells 14,687 Shares of Cigna Group $CI

Key Points

• Kingsview Wealth Management cut its Cigna Group stake by 30% in the fourth quarter, selling 14,687 shares and leaving it with 34,307 shares valued at about $9.44 million.
• Cigna reported strong quarterly results, with EPS of $7.79 beating expectations and revenue of $68.52 billion also topping forecasts; the company reiterated FY 2026 guidance around 30.35 EPS.
• The company declared a quarterly dividend of $1.56 per share, while analysts remain broadly positive with a consensus Moderate Buy rating and an average price target of $339.50.

Kingsview Wealth Management LLC trimmed its position in Cigna Group (NYSE:CI - Free Report) by 30.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 34,307 shares of the health services provider's stock after selling 14,687 shares during the quarter. Kingsview Wealth Management LLC's holdings in Cigna Group were worth $9,442,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in CI. Northwestern Mutual Wealth Management Co. grew its holdings in Cigna Group by 13,333.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider's stock worth $900,912,000 after acquiring an additional 3,141,844 shares in the last quarter. Capital Research Global Investors raised its holdings in shares of Cigna Group by 140.2% in the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider's stock valued at $916,434,000 after purchasing an additional 1,855,897 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Cigna Group by 8.3% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider's stock valued at $3,249,113,000 after purchasing an additional 903,334 shares in the last quarter. Ameriprise Financial Inc. lifted its position in shares of Cigna Group by 54.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider's stock worth $615,781,000 after purchasing an additional 753,865 shares during the period. Finally, M&T Bank Corp boosted its stake in shares of Cigna Group by 1,299.3% during the fourth quarter. M&T Bank Corp now owns 635,706 shares of the health services provider's stock valued at $174,965,000 after purchasing an additional 590,277 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

Cigna Group Stock Performance

Shares of CI stock opened at $284.62 on Friday. The business's fifty day simple moving average is $278.07 and its 200-day simple moving average is $276.88. The company has a market cap of $75.29 billion, a PE ratio of 12.07, a PEG ratio of 1.03 and a beta of 0.30. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts' consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion during the quarter, compared to analysts' expectations of $66.29 billion. During the same quarter last year, the firm earned $6.74 EPS. The business's quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group's payout ratio is presently 26.45%.

Insider Activity

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the business's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO David Cordani sold 201,878 shares of the company's stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 205,904 shares of company stock worth $60,277,068 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Leerink Partners lifted their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the company a "market perform" rating in a report on Friday, February 6th. Morgan Stanley increased their target price on Cigna Group from $355.00 to $361.00 and gave the company an "overweight" rating in a research report on Wednesday, May 20th. UBS Group lifted their price target on Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a report on Friday, May 22nd. Raymond James Financial set a $340.00 price objective on Cigna Group in a research note on Friday, May 1st. Finally, TD Cowen raised their price objective on Cigna Group from $333.00 to $338.00 and gave the company a "buy" rating in a research report on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $339.50.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.